Juvenile laryngeal papillomatosis

Area of Science:

• Otolaryngology
• Pediatric Oncology
• Virology

Background:

• Juvenile laryngeal papillomatosis (JLP) is a rare condition affecting the larynx in children.
• The etiology is linked to the human papillomavirus (HPV).
• JLP can cause significant airway obstruction and voice impairment.

Purpose of the Study:

• To review the etiology, natural history, and treatment outcomes of JLP.
• To evaluate the effectiveness of current and emerging therapies for JLP.
• To provide guidance on managing JLP, emphasizing avoiding tracheostomy.

Main Methods:

• Retrospective case series analysis of 23 patients with JLP.
• Review of clinical records, treatment modalities, and patient outcomes.
• Assessment of viral etiology and disease behavior.

Main Results:

• JLP exhibits unpredictable behavior and requires prolonged, often frustrating, treatment.
• Tracheostomy is associated with risks of further dissemination and should be avoided.
• CO2 laser treatment is the current surgical choice, with early positive results from adjuvant interferon therapy.

Conclusions:

• JLP is a challenging viral-induced condition requiring careful management.
• CO2 laser surgery and interferon therapy represent advancements in JLP treatment.
• Limited availability of laser technology and interferon necessitates further research and accessibility efforts.